Merck & Co. Inc. (NYSE:MRK) known as MSD outside the US and Canada, and Eli Lilly and Company (LLY) announced an oncology clinical trial collaboration to evaluate the safety, tolerability and efficacy of KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 therapy, in combination with Lilly compounds in multiple clinical trials. On Tuesday shares of Merck & Co. Inc. (NYSE:MRK) closed at $62.19. Company’s sales growth for last 5 years was 13.00% and EPS growth for next 5 years is recorded as 6.70%.

PhotoMedex (NASDAQ:PHMD) CFO Dennis M. Mcgrath sold 55,000 shares of PhotoMedex stock in a transaction dated Tuesday, December 16th. The shares were sold at an average price of $1.14, for a total transaction of $62,700.00. Following the transaction, the chief financial officer now directly owns 256,136 shares of the company’s stock, valued at approximately $291,995. PhotoMedex, Inc. (NASDAQ:PHMD) in last trading activity fell -0.56% to close at $1.79. Company weekly performance is 21.77% while its quarterly performance stands at -65.11%. PhotoMedex, Inc. (NASDAQ:PHMD) is -89.36% away from its 52 week high.

AV Homes Inc. (NASDAQ:AVHI) CEO Roger A. Cregg purchased 10,000 shares of the stock in a transaction that occurred on Tuesday, December 9th. The shares were purchased at an average cost of $13.79 per share, with a total value of $137,900.00. On last trading day AV Homes, Inc. (NASDAQ:AVHI) fell -1.67% to close at $14.69. Its volatility for the week is 2.23% while volatility for the month is 3.56%. AVHI’s sales growth for past 5 years was 5.40% and its EPS growth for past 5 years was 36.40%. AV Homes, Inc. (NASDAQ:AVHI) monthly performance is 6.99%.

Johnson & Johnson (NYSE:JNJ)’s drug company, Janssen, will pay up to $241 million plus potential royalties to Cambridge biotech Vedanta Biosciences to license and develop its microbiome-based drug for inflammatory bowel disease. Johnson & Johnson (NYSE:JNJ) has 0.01% insider ownership while its institutional ownership stands at 67.50%. In last trading activity company’s stock closed at $104.76.

SunEdison, Inc. (NYSE:SUNE) has announced the signing of a memorandum of understanding with the state government of Karnataka in India to develop five gigawatts of solar energy and wind power in the state over the next five years. On last trading day SunEdison, Inc. (NYSE:SUNE) increased 2.96% to close at $20.51. Its volatility for the week is 4.73% while volatility for the month is 4.73%. SUNE’s EPS growth for past 5 years was -28.10%. SunEdison, Inc. (NYSE:SUNE) monthly performance is 7.83%.